Who invested in Profusa?
Profusa's investors include Asset Management Ventures, Atinum Investment, 3E Bioventures, Tasly Pharmaceutical and Maxim Integrated.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$60Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $45M sold, first sale May 2018
No investor was named in the report.
From a historical funding recordSEC filing: $11M sold, first sale Jun 2015
Reported by sec.govSEC filing: $2.8M sold, first sale Aug 2013
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Oct 2011
From Profusa's own website and the SEC filings it signed: 1 founder, 5 on the team.
On the board, as filediJoan Siu BraddiNG Siu WaiQianye Karen LiuThomas GutshallWilliam Siu Frist
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Profusa's investors include Asset Management Ventures, Atinum Investment, 3E Bioventures, Tasly Pharmaceutical and Maxim Integrated.
Profusa has raised $60M across 4 rounds since 2012.
Profusa's most recent round was a Series C of $45M in Aug 2018.
Its most recent round, $45M in Aug 2018, is also its largest on record.
Profusa's first round on record, in Sept 2013, was backed by Asset Management Ventures.
Profusa's latest named round is a Series C, in Aug 2018.
Profusa is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.